Clinical Scorecard: Interactions of Synaptic Proteins in Neurological Disorders

At a Glance

Key Highlights

• Disruption of synaptic balance can lead to various neurological disorders.
• AMPA receptors play a crucial role in synaptic strength and plasticity.
• Human brain tissue studies reveal chronic depletion of synaptic proteins in epilepsy.
• Shared genetic architecture links ASD and epilepsy through presynaptic dysfunction.
• S100B protein may protect against amyloid-β toxicity in Alzheimer's disease.

Guideline-Based Recommendations

Diagnosis

• Utilize human tissue samples for accurate pathology in epilepsy research.
• Consider genetic risk factors in the assessment of ASD and epilepsy.

Management

• Explore therapeutic strategies targeting synaptic dysfunction.
• Investigate the role of presynaptic alterations in treatment approaches.

Monitoring & Follow-up

• Assess AMPA receptor phosphorylation levels in epilepsy patients.
• Monitor S100B expression in relation to amyloid-β exposure.

Risks

• Chronic seizure conditions may lead to synaptic protein depletion.
• Early life seizure history could impact excitatory synaptic regulation.

Patient & Prescribing Data

Individuals with drug-resistant temporal lobe epilepsy and Alzheimer's disease

Focus on synaptic integrity and receptor dynamics for potential therapeutic interventions.

Clinical Best Practices

• Integrate findings from basic structural biology into clinical practice.
• Utilize precision medicine approaches based on genetic insights.

Related Resources & Content

• Research Topic on Synaptic Proteins